Wuxi Further Pharmaceutical Co., Ltd

Founded in 2012 and headquartered in Wuxi City, Jiangsu Province, Wuxi Further Pharmaceutical Co., Ltd. is a comprehensive international pharmaceutical science and technology manufacturing enterprise specializing in the R&D, production and sales of characteristic APIs (including intermediates) and finished drugs. It is one of the enterprises exporting the most varieties of characteristic APIs and intermediates in China for many consecutive years. The company's products cover the treatment fields of the cardiovascular, central nervous, diabetes. The core products Voglibose, Folic acid, Clopidogrel, Avanafi, Cozotinib, Atorvastatin Ca, Pregabalin, and other products have formed a commercialized R&D, production and sales system of the whole industrial chain.